|
Source | Age | Risk factors | Clinical presentation | Immunohistochemistry | Location, size | Treatment | Followup
|
|
Beckman et al. [1] | 78 | Prolonged estrogen therapy | Not reported | Not reported | Prostatic urethral crest | Not reported | Not reported |
|
González et al. [2] | 52 | Cirrhosis, spironolactone use, 2x inguinal hernia repair | Stabbing pelvic pain | Epithelium: ER+, PR+ Stroma: CD10+ | R. inguinal area, attached to bladder serosa, 2.5 cm | Surgical resection | Not reported |
|
Fukunaga [3] | 69 | 9 years of hormonal therapy for prostatic adenocarcinoma, 1 year of radiotherapy and chemotherapy | Swelling of the left testis on a routine examination | Vimentin+, CD10+, ER+, PR+ | L. paratestis, cm | Bilateral orchiectomy | Not reported |
|
Giannarini et al. [4] | 27 | Not reported | 2 weeks of postcoital left scrotal pain | ER+, PR+, CK7, 8, 18, 19+, vimentin, CEA, CD10− | Head of the L. epididymis, 1.7 cm | Surgical resection | Asymptomatic at 5 years |
|
Young and Scully [5] | 82 | 3 years of DES for prostatic adenocarcinoma | Palpable firm mass on the tail of the epididymis on routine examination | Not reported | Between vas deferens and testis, close to the tail of the epididymis, 5 cm | Bilateral orchiectomy | Died 9 months later due to metastatic prostatic adenocarcinoma |
|
Jabr and Mani [6] | 52 | Cirrhosis secondary to Hep. C; inguinal hernia repair with mesh | Right lower quadrant pain | ER+, PR+, CD10+ | Cystic mass attached to urinary bladder and right inguinal area, cm | Surgical resection | Asymptomatic |
|
Martin and Hauck [7] | 83 | TACE therapy for prostatic adenocarcinoma | Not reported | Not reported | Lower abdominal wall | Not reported | Not reported |
|
Oliker and Harris [8] | 80 | Prolonged hormonal therapy | Not reported | Not reported | Bladder | Not reported | Not reported |
|
Pinkert et al. [9] | 50 | TACE therapy for prostatic adenocarcinoma | Hematuria, hydroureter | H&E | Ulceration surrounding trigonal area, bladder muscular wall | Surgical resection, discontinued hormonal therapy | Asymptomatic at 4 years |
|
Tulunay et al. [10] | 43 | Within clear cell carcinoma of tunica vaginalis | Hemoptysis, abdominal pain, weight loss | H&E | Left paratestis | Left orchiectomy | Died 2 weeks later due to tumor progression |
|
Schrodt et al. [11] | 73 | 5-year hormonal therapy for prostate adenocarcinoma | Right hydronephrosis | Not reported | Right ureterovesical junction | Not reported | Not reported |
|
Simsek et al. [12] | 49 | Inguinal hernia repair ×3 | Intraoperative hernia repair, mass discovered along the spermatic cord | H&E | Left ductus deferens, cm | Surgical resection | Not reported |
|
Taguchi et al. [13] | 74 | Radical prostatectomy for prostatic adenocarcinoma; leuprorelin and ethinylestradiol for 5 years | Painless macrohematuria | ER+, PR+, CD10+, PSA− | Left ureteral orifice, 3 cm | Surgical resection, discontinued hormonal therapy | Tumor shrank on imaging; no PSA elevation at 6 months |
|
Zamecnik and Hostakova [14] | 46 | Obesity, BMI of 31 | Cyst found adjacent to seminoma | Epithelium: ER+, PR+, CK5,6,7+, calretinin+, EMA+ Stroma: PR+, calretinin+, CD10+ | Within mesothelial cyst of tunica vaginalis; 4 mm focus of endometriosis found in 7 mm cyst | Right-sided orchiectomy | Not reported |
|
Scully [15] | Not reported | Hormonal therapy for prostate adenocarcinoma | Not reported | Not reported | Scrotum | Not reported | Not reported |
|
Scully [15] | Not reported | Hormonal therapy for prostate adenocarcinoma | Not reported | Not reported | Scrotum | Not reported | Not reported |
|
Present case | 40 | Obesity, BMI of 35.7 | Right lower quadrant abdominal pain radiating to the right flank | CK7+, ER+, CD10+, CD15+, GATA-3− | Right vas deferens, cm | Surgical resection | Asymptomatic at 2 weeks |
|